Advances in treating glioblastoma

por Weathers, Shiao-Pei, Gilbert, Mark R.
Publicado 2014

Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1(N546K) Mutation

por Capone, Stephen, Ketonen, Leena, Weathers, Shiao-Pei, Subbiah, Vivek
Publicado 2022

Potential neurologic and oncologic implications of the novel coronavirus

por Aaroe, Ashley Elimar, Majd, Nazanin, Weathers, Shiao-Pei, de Groot, John Frederick
Publicado 2020

A research protocol for a pilot, randomized controlled trial designed to examine the feasibility of a dyadic versus individual yoga program for family caregivers of glioma patients...

por Milbury, Kathrin, Li, Jing, Weathers, Shiao-Pei, Shih, Tina, Malliaha, Smitha, Li, Yisheng, Cohen, Lorenzo
Publicado 2019

Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews

por Acquaye, Alvina A., Payén, Samuel S., Vera, Elizabeth, Williams, Loretta A., Gilbert, Mark R., Weathers, Shiao-Pei, Armstrong, Terri S.
Publicado 2019

Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma

por Nelson, Blessie Elizabeth, Reddy, Neha K., Huse, Jason T., Amini, Behrang, Nardo, Mirella, Gouda, Mohamed, Weathers, Shiao-Pei, Subbiah, Vivek
Publicado 2023

Pre-surgical connectome features predict IDH status in diffuse gliomas

por Kesler, Shelli R., Harrison, Rebecca A., Petersen, Melissa L., Rao, Vikram, Dyson, Hannah, Alfaro-Munoz, Kristin, Weathers, Shiao-Pei, de Groot, John
Publicado 2019

Dual inhibition of BRAF and mTOR in BRAF(V600E)-mutant pediatric, adolescent, and young adult brain tumors

por Sen, Shiraj, Tanaka, Ryuma, Khatua, Soumen, Zaky, Wafik, Janku, Filip, Penas-Prado, Marta, Weathers, Shiao-Pei, Behrang, Amini, Roszik, Jason, Subbiah, Vivek
Publicado 2020

Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2

por Wang, Michael, Jain, Preetesh, Chi, T Linda, Chen, Sheree E, Heimberger, Amy, Weathers, Shiao-Pei, Zheng, Lianqing, Rao, Arati V, Rossi, John M
Publicado 2020

Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor

por Joseph, Jocelyn, Nathenson, Michael J., Trinh, Van Anh, Malik, Karan, Nowell, Erica, Carter, Kristen, Weathers, Shiao-Pei, Demetri, George D., Araujo, Dejka, Conley, Anthony P.
Publicado 2019

Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma

por Weathers, Shiao-Pei, Rood-Breithaupt, Julie, de Groot, John, Thomas, Gail, Manfrini, Marianna, Penas-Prado, Marta, Puduvalli, Vinay K, Zwingelstein, Christian, Yung, W K Alfred
Publicado 2021

Dyadic versus individual delivery of a yoga program for family caregivers of glioma patients undergoing radiotherapy: Results of a 3‐arm randomized controlled trial

por Milbury, Kathrin, Whisenant, Meagan, Weathers, Shiao‐Pei, Malliaha, Smitha, Snyder, Stella, Jackson, Natalie, Li, Jing, Li, Yisheng, Silva, Roseanglea F., Shih, Ya‐Chen Tina, Cohen, Lorenzo
Publicado 2022

COVD-30. A SNAPSHOT OF THE IMPACT OF COVID-19 ON PATIENTS WITH NERVOUS SYSTEM TUMORS

por Aaroe, Ashley, Harrison, Rebecca, Majd, Nazanin, O’Brien, Barbara, Weathers, Shiao-Pei, Loghin, Monica, Kamiya-Matsuoka, Carlos, Yung, W K Alfred, de Groot, John, Woodman, Karin
Publicado 2020

Aggressiveness of care at end of life in patients with high‐grade glioma

por Harrison, Rebecca A., Ou, Alexander, Naqvi, Syed M. A. A., Naqvi, Syed M., Weathers, Shiao‐Pei S., O'Brien, Barbara J., de Groot, John F., Bruera, Eduardo
Publicado 2021

GBM-associated mutations and altered protein expression are more common in young patients

por Ferguson, Sherise D., Xiu, Joanne, Weathers, Shiao-Pei, Zhou, Shouhao, Kesari, Santosh, Weiss, Stephanie E., Verhaak, Roeland G., Hohl, Raymond J., Barger, Geoffrey R., Reddy, Sandeep K., Heimberger, Amy B.
Publicado 2016

Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk

por Noticewala, Sonal S., Ludmir, Ethan B., Bishop, Andrew J., Chung, Caroline, Ghia, Amol J., Grosshans, David, McGovern, Susan, Paulino, Arnold de la Cruz, Wang, Chenyang, Woodhouse, Kristina D., Yeboa, Debra N., Prabhu, Sujit S., Weathers, Shiao-Pei, Das, Prajnan, Koong, Albert C., McAleer, Mary Frances, Li, Jing
Publicado 2020

LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE

por Sinicrope, Kaylyn D, Barata, Pedro, Walker, Julie, Tremont-Lukats, Ivo W, Groves, Morris, Loghin, Monica, Seligman, Christa, Ferguson, Sherise, Weathers, Shiao-Pei, Penas-Prado, Marta, Kamiya-Matsuoka, Carlos, Harrison, Rebecca, Tummala, Sudhakar, Trevino, Christopher R, Peinado, Shanta, Murthy, Rashmi K, Seyedeh, Dibaj, de Groot, John, O’Brien, Barbara
Publicado 2019

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma

por de Groot, John, Ott, Martina, Wei, Jun, Kassab, Cynthia, Fang, Dexing, Najem, Hinda, O'Brien, Barbara, Weathers, Shiao-Pei, Matsouka, Carlos Kamiya, Majd, Nazanin K, Harrison, Rebecca A, Fuller, Gregory N, Huse, Jason T, Long, James P, Sawaya, Raymond, Rao, Ganesh, MacDonald, Tobey J, Priebe, Waldemar, DeCuypere, Michael, Heimberger, Amy B
Publicado 2022

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience

por Gregory, Timothy A, Mastall, Maximilian, Lin, Heather, Hess, Kenneth R, Yuan, Ying, Martin-Bejarano Garcia, Manuela, Fuller, Gregory N, Alfaro, Kristin D, Gule-Monroe, Maria K, Huse, Jason T, Khatua, Soumen, Rao, Ganesh, Sandberg, David I, Wefel, Jeffrey S, Yeboa, Debra N, Paulino, Arnold C, McGovern, Susan L, Zaky, Wafik, Mahajan, Anita, Suki, Dima, Weathers, Shiao-Pei, Harrison, Rebecca A, de Groot, John F, Puduvalli, Vinay K, Penas-Prado, Marta, Majd, Nazanin K
Publicado 2023

Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience

por Majd, Nazanin K, Mastall, Maximilan, Lin, Heather, Dibaj, Seyede Shiva, Hess, Kenneth R, Yuan, Ying, Garcia, Manuela Martin-Bejarano, Fuller, Gregory N, Alfaro, Kristin D, Gule-Monroe, Maria K, Huse, Jason T, Khatua, Soumen, Rao, Ganesh, Sandberg, David I, Wefel, Jeffrey S, Yeboa, Debra N, Paulino, Arnold C, McGovern, Susan L, Zaky, Wafik, Mahajan, Anita, Suki, Dima, Weathers, Shiao-Pei, Harriso, Rebecca A, De Groo, John F, Puduvalli, Vinay K, Penas-Prado, Marta
Publicado 2021